Ticker
INMCompany Name
INMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 5.1M | $ 13.16M | $ 0 | -257.84% |
3/31/2025 | $ 2.75M | $ 4.36M | $ 0 | -158.45% |
12/31/2024 | $ 3.86M | $ 1.43M | $ 0 | -36.92% |
9/30/2024 | $ 3.65M | $ 5.68M | $ 0 | -155.83% |
6/30/2024 | $ 3.16M | $ 4.65M | $ 0 | -147.2% |
3/31/2024 | $ 2.23M | $ 4.65M | $ 0 | -208.55% |
12/31/2023 | $ 2.16M | $ 4.65M | $ 0 | -215.97% |
9/30/2023 | $ 2.03M | $ 6M | $ 0 | -295.8% |
6/30/2023 | $ 2.33M | $ 12M | $ 0 | -515.17% |
3/31/2023 | $ 3.86M | $ 17.15M | $ 0 | -444.13% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for INMED PHARMACEUTICALS INC is calculated as follows: (-1 * CF - Equity [ $ 0 ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 20.83M ]
(=) Payout Yield [ 0% ]
Minimum
Jun 30, 2023
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.11% |